WallStreetZenWallStreetZen

NASDAQ: IMCC
IM Cannabis Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their IMCC stock forecasts and price targets.

Forecast return on equity

Is IMCC forecast to generate an efficient return?

Company
-72.22%
Industry
184.14%
Market
261.14%
IMCC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IMCC forecast to generate an efficient return on assets?

Company
-6.19%
Industry
103.6%
IMCC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IMCC earnings per share forecast

What is IMCC's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.47
Avg 2 year Forecast
-$0.46

IMCC revenue forecast

What is IMCC's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$79.5M+107.77%
Avg 2 year Forecast
$89.7M+134.43%
IMCC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IMCC revenue growth forecast

How is IMCC forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
107.77%
Industry
3,347.39%
Market
1,348.83%
IMCC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IMCC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IMCC vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
IMCC$1.47N/AN/A
CPHI$1.73N/AN/A
SNOA$3.95N/AN/A
FLGC$9.24N/AN/A
KALA$0.76$32.67+4,221.03%Buy
View Top Pharmaceutical Stocks

IM Cannabis Stock Forecast FAQ

What is IMCC's earnings growth forecast for 2025-2026?

(NASDAQ: IMCC) IM Cannabis's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 43,010.73%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,853.53%.

IM Cannabis's earnings in 2025 is -$823,357.On average, 3 Wall Street analysts forecast IMCC's earnings for 2025 to be -$1,881,242, with the lowest IMCC earnings forecast at -$1,807,626, and the highest IMCC earnings forecast at -$1,936,656.

In 2026, IMCC is forecast to generate -$1,856,569 in earnings, with the lowest earnings forecast at -$1,783,762 and the highest earnings forecast at -$1,911,174.

If you're new to stock investing, here's how to buy IM Cannabis stock.

What is IMCC's revenue growth forecast for 2025-2026?

(NASDAQ: IMCC) IM Cannabis's forecast annual revenue growth rate of 107.77% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 3,347.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,348.83%.

IM Cannabis's revenue in 2025 is $38,258,394.On average, 3 Wall Street analysts forecast IMCC's revenue for 2025 to be $321,526,151, with the lowest IMCC revenue forecast at $308,914,427, and the highest IMCC revenue forecast at $330,982,921.

In 2026, IMCC is forecast to generate $362,783,233 in revenue, with the lowest revenue forecast at $348,553,584 and the highest revenue forecast at $373,453,447.

What is IMCC's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: IMCC) forecast ROA is -6.19%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 103.6%.

What is IMCC's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: IMCC) IM Cannabis's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that IMCC's EPS will be -$0.47 for 2025, with the lowest EPS forecast at -$0.45, and the highest EPS forecast at -$0.48. In 2026, IMCC's EPS is forecast to hit -$0.46 (min: -$0.44, max: -$0.47).

What is IMCC's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: IMCC) forecast ROE is -72.22%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.